| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -7.00 | -2.48% | 275.00 | 270.00 | 280.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 282.00 | 275.00 | 282.00 | 12,944 | 09:02:08 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0.0 | -28.7 | -48.0 | - | 174.62 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
| Date | Time | Source | Headline |
|---|---|---|---|
| 24/4/2023 | 14:21 | ALNC |  Faron Pharmaceuticals test data shows efficacy of bexmarilimab |
| 24/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Bexmarilimab Efficacy and Safety in MATINS Trial |
| 19/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Bexmarilimab KOL Event |
| 18/4/2023 | 07:00 | RNSNON | Faron Pharmaceuticals Oy Poster Presentations at AACR 2023 |
| 17/4/2023 | 16:34 | ALNC | TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody |
| 17/4/2023 | 07:00 | UKREG | Faron Pharmaceuticals Oy BEXMAB study update |
| 13/4/2023 | 16:30 | RNSNON | Faron Pharmaceuticals Oy Faron at Canaccord Oncology Virtual Conference |
| 29/3/2023 | 10:42 | ALNC | Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO |
| 29/3/2023 | 07:00 | UKREG | Faron Pharmaceuticals Oy Appointment of Chief Financial Officer |
| 24/3/2023 | 13:35 | UKREG | Faron Pharmaceuticals Oy Board Change |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |